Julie Hambleton Net Worth & Insider Trades
Julie Hambleton - Director, Igm Biosciences, Inc
What is Julie Hambleton's Net Worth?
The current estimated net worth of Igm Biosciences, Inc's Director, Julie Hambleton, is estimated to be about $1.38M . Julie Hambleton owns about 2,000 units of Igm Biosciences, Inc common stock. In the last 3 years at Igm Biosciences, Inc, Julie Hambleton has sold an estimated value of $240K worth.
What is Julie Hambleton's Past Insider Trading?
Julie Hambleton's largest purchase order was 5,000 units , worth over $91.55K on September 20, 2019. Julie Hambleton's largest sale order was 2,000 units , worth over $160K on June 3, 2021. In total, Julie Hambleton has made about 7 transactions over 3 years of their time at Igm Biosciences, Inc. Julie Hambleton usually trades in September and February, with the busiest year in 2021. The most recent transaction was a sale order of 1,000 units , worth over $80K on August 11, 2021.
Julie Hambleton
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
---|---|---|---|---|---|---|---|
No matching records found |
What is Julie Hambleton's' Mailing Address?
- Mailing address is C/o Five Prime Therapeutics, Inc. Two Corporate Drive South San Francisco CA 94080 CA
Igm Biosciences, Inc Executive Compensation
Name |
Year
|
Salary
|
Option Awards
|
Other Earnings Plans or Compensations
|
Total
|
---|---|---|---|---|---|
Fred Schwarzer | 2020 | $529,700 | $4,251,990 | $317,820 | $5,099,510 |
Fred Schwarzer | 2019 | $428,000 | $121,189 | $207,911 | $757,100 |
Bruce Keyt, Ph.D. | 2020 | $413,200 | $2,125,995 | $223,128 | $2,762,323 |
Bruce Keyt, Ph.D. | 2019 | $357,000 | $92,714 | $151,743 | $601,457 |
Daniel S. Chen, M.D., Ph.D. | 2020 | $456,250 | $1,559,063 | $219,000 | $2,234,313 |
No matching records found |
Source: https://www.sec.gov/Archives/edgar/data/1496323/000119312521140868/d151412ddef14a.htm
What are Igm Biosciences, Inc's Past Insider Trades?
Igm Biosciences, Inc's most recent insider trade came on March 16, 2023 by Chris Takimoto who sold 1,768 units worth $33.12K . In the last 4 years, insiders at Igm Biosciences, Inc have sold an estimated value of $12.44M and bought an estimated value of $243.53M worth of shares. Insider trading is most common in March and September, with the busiest year in 2022. The most active traders at the company are Bruce Keyt, Chief Scientific Officer, Haldor Jakob Topsoe, Director, and Kathleen Behrens, Director .
IGM Biosciences, Inc. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
---|---|---|---|---|---|---|---|
No matching records found |